Founded in 2017, Newmanbrain company  was born with the mission of making unbiased cognitive assessment available for mass screening. We wanted to build an accessible and easy to use system that clinicians and patients would “thrive” to use on a daily basis.

We seek collaboration based on the recognized qualifications of our teams, the high reputation of our managers, their experience in projects of this nature, and their scientific and international connections both in the clinical and scientific community and in the relevant corporate world. We would like to collaborate on clinical trials, the recruitment of engineers and other personnel to compile the THEIA® product dossier, access to external engineering consultants and services from NMB, and clinical evaluation by independent groups.

Our goal is to convert the technological advantage into a true competitive advantage, that is, in those attributes of recognition (percentage of professionals who know us) and positioning (percentage of professionals who put us at an advantage over possible competitors to make a decision) for our brand.

We believe that as a private company based on neuroscience and AI, which has been able to create an approved medical device and which operates in the private technological and financial world, we can help different groups make some projects related to applied science a reality.